| Customization: | Available |
|---|---|
| Powder: | Yes |
| Customized: | Customized |
|
Still deciding? Get samples of $ !
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
Product Name: Dasatinib Monohydrate
Form: Powder
Purity: 99%
MF: C22H28ClN7O3S
CAS No.: 863127-77-9
Brand: Salus
COA: Available
Sample: Available
Shelf Life: 2 Years
Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cance
Specification:
|
Item |
Specification |
|
Appearance |
White Powder |
|
Assay(HPLC) |
≥99% |
|
Solutility |
Insoluble in water and slightly soluble in ethanol and meth |
|
Identification a)1H-NMR b)Retention time(HPLC) |
Conforms to standard Conforms to standard |
|
Melting point |
275.0-286.0°C |
|
Water Content(KF) |
2.8-4.2% |
|
Residue on ignition |
≤0.2%
|
|
Heavy metals |
≤20ppm |
|
Related substances Any single impurities Total impurities |
≤0.5% ≤1.0% |
Dasatinib is an oral Bcr-Abl tyrosine kinase inhibitor (inhibits the "Philadelphia chromosome") and Src family tyrosine kinase inhibitor approved for first line use in patients with chronic myelogenous leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). It is being evaluated for use in numerous other cancers, including advanced prostate cancer.
){kind=link}